His scientific interests lie mostly in Peptidoglycan, Immune system, Immunology, NOD1 and Microbiology. Ivo G. Boneca interconnects Innate immune system, NOD2 and Signal transduction in the investigation of issues within Peptidoglycan. His research integrates issues of Cyclophosphamide and Gram-positive bacteria in his study of Immune system.
Immunology is closely attributed to Cancer research in his study. His NOD1 research is multidisciplinary, relying on both Nod1 Signaling Adaptor Protein, Toll-like receptor, Yersinia pseudotuberculosis and Cell biology. The Microbiology study combines topics in areas such as Staphylococcus aureus, Listeria monocytogenes, Receptor, Escherichia coli and Cell wall.
Ivo G. Boneca mainly focuses on Microbiology, Peptidoglycan, Innate immune system, Bacteria and Immune system. His Microbiology study combines topics from a wide range of disciplines, such as Lipopolysaccharide, TLR2, Helicobacter pylori and Virulence. His Peptidoglycan research is multidisciplinary, incorporating perspectives in NOD1 and Cell biology.
His NOD1 study integrates concerns from other disciplines, such as Toll-like receptor and Intracellular. Ivo G. Boneca has included themes like Reactive nitrogen species and Flagellin in his Innate immune system study. His Immune system study deals with the bigger picture of Immunology.
His main research concerns Microbiology, Peptidoglycan, Bacterial cell structure, Cell biology and Cell wall. The study incorporates disciplines such as Lipopolysaccharide, Innate immune system and Virulence in addition to Microbiology. The Virulence study which covers Leptospirosis that intersects with Immune system.
His Immune system study incorporates themes from Microbiome, Cancer, Colorectal cancer and Cancer research. Peptidoglycan is the topic of his studies on Bacteria and Biochemistry. His biological study spans a wide range of topics, including House dust mite, Allergen, Immunology, Asthma and Allergy.
Microbiology, Innate immune system, Bacterial cell structure, Leptospira and Cell wall are his primary areas of study. In his works, Ivo G. Boneca performs multidisciplinary study on Microbiology and Prophage. His work in Pattern recognition receptor and TLR2 is related to Innate immune system.
His work deals with themes such as Chemokine, NOD2, Immunity and Leptospira interrogans, which intersect with TLR2. His Bacterial cell structure research incorporates themes from Periplasmic space, Toll-like receptor, TLR5, NOD1 and Flagellin. His Cell wall research entails a greater understanding of Biochemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
Stephen E. Girardin;Ivo G. Boneca;Jérôme Viala;Mathias Chamaillard.
Journal of Biological Chemistry (2003)
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
Stephen E Girardin;Ivo G Boneca;Leticia A M Carneiro;Aude Antignac.
Science (2003)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage.
Science (2015)
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
Djahida Bouskra;Christophe Brézillon;Marion Bérard;Catherine Werts;Catherine Werts.
Nature (2008)
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki.
Science (2013)
Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.
Stephen E. Girardin;Leonardo H. Travassos;Mireille Hervé;Didier Blanot.
Journal of Biological Chemistry (2003)
Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition
Leonardo H Travassos;Leonardo H Travassos;Stephen E Girardin;Dana J Philpott;Didier Blanot.
EMBO Reports (2004)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Marie Vétizou;Marie Vétizou;Marie Vétizou;Romain Daillère;Romain Daillère;Romain Daillère;María Paula Roberti;María Paula Roberti.
Immunity (2016)
Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells.
Ehud Zigmond;Ehud Zigmond;Chen Varol;Julia Farache;Elinor Elmaliah.
Immunity (2012)
The microbiota regulates type 2 immunity through RORγt+ T cells
Caspar Ohnmacht;Joo Hong Park;Sascha Cording;James B. Wing.
Science (2015)
Microbial Drug Resistance
(Impact Factor: 2.706)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Toronto
Institut Pasteur
Institut Pasteur
University of Toronto
Institut Pasteur
University of Lille
Hudson Institute of Medical Research
Sorbonne University
University of Paris-Saclay
University of Paris-Saclay
New York University
Imperial College London
Southeast University
Northwestern Polytechnical University
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
China University of Geosciences
Pacific Marine Environmental Laboratory
University of Cologne
University of Pennsylvania
Catholic University of the Sacred Heart
Virginia Commonwealth University Medical Center
Kyoto University
Yale University
Yale University
Harvard University